Cingulate Inc (CING) has released an update to notify the public and investors about its officers.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Jennifer L. Callahan was appointed as the Senior Vice President and Chief Financial Officer of the Company on January 25, 2024. Bringing a wealth of experience from her previous accounting roles and a CPA designation, Callahan’s employment agreement provides for a reduced annual base salary of $210,000 due to cost-containment measures, with the promise of a catch-up payment post the filing of a new drug application, and a target annual bonus of 25%. The agreement also outlines severance benefits, stock option vesting conditions, and participation in executive compensation programs, subject to company performance and her individual evaluation.
For further insights into CING corporate activity, check out TipRanks’ Insiders Trading Activity page.